MKI67 and central nervous system cancer: As with glioma, the proliferation marker Ki67, which is used as a prognostic marker in various tumors, may also play a role in both 5-ALA fluorescence and as a prognostic marker in histologically different brain metastases, which have already shown a correlation between 5-ALA fluorescence rate and prolonged survival in our study.